日本《腹膜播散诊疗指南(2021版)》解读  

Interpretation of the Japanese peritoneal dissemination diagnosis and treatment guidelines(2021 edition)

作　　者：李伟[1] 所剑[1] LI Wei;SUO Jian(Department of Gastric and Colorectal Surgery,General Surgery Center,the First Hospital of Jilin University,Changchun 130021,China)

机构地区：[1]吉林大学第一医院普通外科中心胃结直肠外科,吉林长春130021

出　　处：《中国实用外科杂志》2024年第1期24-37,共14页Chinese Journal of Practical Surgery

基　　金：吉林省医疗卫生人才专项(No.JLSWSRCZX2021-094);吉林省科技发展计划项目(No.20220203148 SF)。

摘　　要：日本《腹膜播散诊疗指南(2021版)》是日本腹膜播散研究会经过多年研究与临床实践总结出的权威指南。这部指南详细阐述了发生在腹部的恶性肿瘤导致腹膜播散病人的诊断和治疗方案,为医生提供了重要的参考依据。在手术方面,该指南强调了严格筛选手术适应证的重要性,以确保手术质量和效果,在化学治疗方面,该指南介绍了各种药物和方案的使用方法和效果,为医生和病人提供了全面而准确的信息。同时,该指南还明确了腹膜播散诊疗相关临床问题的推荐度,进一步提升了其指导性和可靠性。了解并借鉴该指南,将有助于提高我国肿瘤腹膜播散的诊疗水平,为病人提供更好的医疗服务。The"Clinical Practice Guidelines for Peritoneal Malignancy 2021",issued by the Japanese Society of Peritoneal Malignancy,is a highly authoritative and comprehensive guideline,formulated on the basis of extensive research and clinical experience.This guideline provides detailed explanations of the diagnosis and treatment options for patients with peritoneal dissemination caused by malignant tumors in the abdomen,serving as an important reference for doctors.In terms of surgery,the guideline emphasizes the importance of strict selection criteria to ensure surgical quality and effectiveness.With regard to chemotherapy,various drugs and protocols are introduced along with their methods of use and effects, providing comprehensive and accurate informationfor both doctors and patients. Additionally, this guidelinespecifies recommended approaches to clinical issues related toperitoneal dissemination diagnosis and treatment, furtherenhancing its guidance and reliability. Understanding thisguideline will contribute to improving China's level ofdiagnosis and treatment for peritoneal malignancy, ultimatelyproviding better medical services for patients.

关 键 词：腹膜播散 诊疗 指南 

分 类 号：R6[医药卫生—外科学]